We at Precisia were thrilled to see last week’s publication by the NHS Confederation of its report 'Women's health economics: investing in the 51%'! The report documents clearly the inequity that women can experience regarding their healthcare and its impact on their quality of life, individual productivity and contribution to the economy and society as a whole. This historic report highlights the potential return on investment (ROI) for every additional £1 that is invested in women’s health services throughout the NHS. It articulates compellingly the strong business case for investing in the 51% to improve women’s health over their whole life course - with a focus on conditions such as cardiovascular disease that affect women differently than men or affect women disproportionately - for the benefit of everybody in society. Read the full report here 👉 https://lnkd.in/ggE9XgkK As proud members of the C2-Ai family, Precisia looks forward to seeing how Clinical Risk Mapping and our Women’s Health Index (WHI) - enabled by C2-Ai’s clinical risk adjustment technology developed by Graham Copeland - can support delivery as we move forward collectively. WHI aggregates detailed clinical risk-adjusted outcomes from individual patients across different key aspects of care. This gives specific insights into the effectiveness of women’s healthcare throughout their lives and across regions. Clinical Risk Mapping and other C2-Ai tools can provide further and deeper levels of insight into unwarranted variation, health inequity and practical actions to improve. Bridget Gorham Olivia Langham Sheuli Porkess Stephen Mackenney Richard A D Jones Mike Roberts Steve Barnett Mark Ratnarajah Claire Louise Bale
Excited to announce that our report 'Women's health economics: investing in the 51%' is finally published! While the genesis of this report is multifaceted, the overarching purpose is to evidence the costs of various women’s health conditions, when left sidelined, to the overall economy; showcase the potential return on investment (ROI) for every additional £1 that is invested in women’s health services throughout the NHS; and to assess the state of women’s health inequalities throughout the country to inform where additional public investment should be directed. Our findings illustrate that for every additional £1 of public investment in obstetrics and gynaecology services per woman in England, there is an estimated ROI of £11. If an additional £1 per woman in England were invested in these services, the economy could benefit from an additional £319 million in total gross value added (GVA). The decision to focus predominantly on the ROI of boosted resource in obstetrics and gynaecology services was deliberate, given the Women’s Health Strategy is mainly focused on sexual health and gynaecology, and this piece’s principal aim is to evidence the benefits of fully funding this ten-year plan. While these areas are important, women’s health spans far beyond this sphere. There are conditions that affect women differently than men such as cardiovascular disease, conditions that affect women disproportionately such as autoimmune diseases, osteoporosis, and migraines, and countless conditions where sex differences are not yet known. Setting out the boundaries of this analysis hopefully elucidates the amount of work left to do – across geographies, conditions, and themes in addition to services, such as research and innovation. It is not our intention to answer every question that relates to investment in women’s health, but rather, to contribute to a very nascent conversation and shed light on opportunities to further this critical work. We call for investment in women’s health that promotes sustainable, inclusive growth, ultimately contributing to both an economy and a health system that work better for everyone. Despite this report’s focus on the relationship between women’s health and economic growth, and the undeniable economic benefits that further investment in women’s health pose, the case for further investment in women’s health is not just about the economy. Health impacts every element of our lives, and access to equitable healthcare that is of appropriate quality and provided without bias or discrimination is a human right that should be protected and guaranteed regardless of the economic benefits it poses to society. While we have made a ROI case, at the heart of this evidence is a view that women have a right to a good quality of life that allows them to participate fully and equally in society. CREATE Health Foundation London Economics Ltd Olivia Langham